Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0232 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0232 |
Peptide Name | NA |
PEPTIDE SEQUENCE (1-letter) | RGD |
PEPTIDE SEQUENCE (3-letter) | ArgGlyAsp |
N-terminal modification | NA |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 3 |
Conformation | Linear |
Peptide Nature | Cationic |
Source/Origin of peptide | Chemically synthesized |
SMILES | NA |
Cell Line | NA |
In vitro CONCENTRATION | NA |
In vitro METHOD | NA |
In vitro RESULT | NA |
ANIMAL MODEL | BALB/c mice xenograft for U87MG glioma cells |
In vivo CONCENTRATION | 5mg/Kg |
In vivo MODE OF DELIVERY | Intravenous |
In vivo METHOD | Fluoroscent measurement |
In vivo RESULT | Significant amount of drugsa delivered in brain tissue |
ACTION | Peptide can deliver drugs into brain tissue |
TRANSPORT TYPE | NA |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | Doxorubicin+paclitaxel in 5mg/Kg combination |
PHYSICAL CONDITION | Brain glioma therapy |
RESPONSE | NA |
RESULT | NA |
LABEL | NA |
PMID | 27143884 |